Ozempic May Reduce Alzheimer’s Risk
Click here to view original web page at Ozempic May Reduce Alzheimer’s Risk Summary: GLP-1 agonists like Ozempic reduce the risk of dementia in type 2 diabetes patients. The research followed over 88,000 individuals for up to ten years, showing a 30% lower risk compared to sulfonylureas and a 23% lower risk compared to DPP-4 … Continue reading “Ozempic May Reduce Alzheimer’s Risk”